| Catalog_no |
ADMC1308 |
| Product_name |
NQ301 |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1000.00/2780.00/5000.00 |
| Specificity |
Target: Thrombin. Fields: NQ301 is a selective CD45 inhibitor (IC50 = 200 nM). Exhibits >200-fold selectivity for CD45 over six related protein tyrosine phosphatases. |
| Dilution |
IC50: 0.60±0.02 μM (collagen-challenged rabbit platelet aggregation), 0.58±0.04 μM (U46619-challenged rabbit platelet aggregation), 0.78±0.04 μM (arachidonic acid-challenged rabbit platelet aggregation)[1] |
| Purification |
>98% |
| Concentration |
靶点：Thrombin;IC50： 0.60±0.02 μM (collagen-challenged rabbit platelet aggregation), 0.58±0.04 μM (U46619-challenged rabbit platelet aggregation), 0.78±0.04 μM (arachidonic acid-challenged rabbit platelet aggregation)[1] |
| Storage_stability |
4 Degree for 1 year, -20 degree for more than 2 years |
| othername |
NQ 301, NQ-301 |
| Molecular Weight |
325.75 |
| Notes |
NQ301 is a selective CD45 inhibitor (IC50 = 200 nM). Exhibits >200-fold selectivity for CD45 over six related protein tyrosine phosphatases. |
| Instructions |
 查看与下载 |
